BNP Paribas Financial Markets lowered its stake in shares of Itron, Inc. (NASDAQ:ITRI - Free Report) by 76.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 431,822 shares of the scientific and technical instruments company's stock after selling 1,366,882 shares during the quarter. BNP Paribas Financial Markets owned about 0.95% of Itron worth $45,238,000 as of its most recent SEC filing.
Several other hedge funds have also recently modified their holdings of ITRI. Mariner LLC increased its holdings in shares of Itron by 6.3% during the fourth quarter. Mariner LLC now owns 3,448 shares of the scientific and technical instruments company's stock valued at $374,000 after acquiring an additional 204 shares in the last quarter. Northern Trust Corp lifted its holdings in shares of Itron by 11.4% during the fourth quarter. Northern Trust Corp now owns 572,266 shares of the scientific and technical instruments company's stock worth $62,137,000 after purchasing an additional 58,546 shares during the period. AQR Capital Management LLC lifted its holdings in shares of Itron by 49.7% during the fourth quarter. AQR Capital Management LLC now owns 152,789 shares of the scientific and technical instruments company's stock worth $16,590,000 after purchasing an additional 50,693 shares during the period. Schonfeld Strategic Advisors LLC lifted its holdings in shares of Itron by 93.1% during the fourth quarter. Schonfeld Strategic Advisors LLC now owns 18,290 shares of the scientific and technical instruments company's stock worth $1,986,000 after purchasing an additional 8,818 shares during the period. Finally, Bayesian Capital Management LP lifted its holdings in shares of Itron by 18.1% during the fourth quarter. Bayesian Capital Management LP now owns 11,100 shares of the scientific and technical instruments company's stock worth $1,205,000 after purchasing an additional 1,700 shares during the period. Institutional investors and hedge funds own 96.19% of the company's stock.
Itron Price Performance
Shares of ITRI stock traded down $0.60 during trading hours on Friday, hitting $120.53. 354,116 shares of the company's stock were exchanged, compared to its average volume of 587,767. The company has a quick ratio of 1.75, a current ratio of 2.04 and a debt-to-equity ratio of 0.48. The firm has a market cap of $5.51 billion, a P/E ratio of 20.56, a P/E/G ratio of 0.66 and a beta of 1.46. The firm has a 50 day moving average of $129.57 and a two-hundred day moving average of $116.47. Itron, Inc. has a fifty-two week low of $90.11 and a fifty-two week high of $140.04.
Itron (NASDAQ:ITRI - Get Free Report) last announced its earnings results on Thursday, July 31st. The scientific and technical instruments company reported $1.62 earnings per share for the quarter, topping the consensus estimate of $1.33 by $0.29. The business had revenue of $606.76 million during the quarter, compared to the consensus estimate of $610.36 million. Itron had a return on equity of 19.69% and a net margin of 11.05%.The business's quarterly revenue was down .4% on a year-over-year basis. During the same period in the prior year, the company posted $1.21 EPS. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. Sell-side analysts forecast that Itron, Inc. will post 5.33 EPS for the current year.
Analyst Ratings Changes
ITRI has been the subject of a number of research reports. Stephens set a $130.00 target price on Itron in a report on Monday, August 4th. JPMorgan Chase & Co. raised Itron from a "neutral" rating to an "overweight" rating and lifted their target price for the stock from $128.00 to $145.00 in a report on Thursday, July 31st. Guggenheim reaffirmed a "buy" rating and set a $155.00 target price (up previously from $133.00) on shares of Itron in a report on Monday, July 14th. Johnson Rice downgraded Itron from a "buy" rating to an "accumulate" rating in a report on Friday, August 1st. Finally, Wall Street Zen raised Itron from a "hold" rating to a "buy" rating in a report on Saturday, August 2nd. Ten research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $136.55.
Get Our Latest Analysis on ITRI
Insider Buying and Selling
In other Itron news, SVP Donald L. Reeves III sold 547 shares of the firm's stock in a transaction on Monday, August 25th. The stock was sold at an average price of $125.31, for a total value of $68,544.57. Following the transaction, the senior vice president owned 19,604 shares in the company, valued at approximately $2,456,577.24. This trade represents a 2.71% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Christopher E. Ware sold 351 shares of the firm's stock in a transaction on Monday, August 25th. The shares were sold at an average price of $125.31, for a total value of $43,983.81. Following the completion of the transaction, the senior vice president owned 19,117 shares in the company, valued at $2,395,551.27. The trade was a 1.80% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 12,073 shares of company stock worth $1,480,880 in the last ninety days. Company insiders own 1.45% of the company's stock.
Itron Company Profile
(
Free Report)
Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.
See Also

Before you consider Itron, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.
While Itron currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report